{"id":"https://openalex.org/W7034209201","doi":null,"title":"Synthesis of ATP-competitive CK1\u03b4 inhibitors: exploring heteroaromatic systems as promising tools for neurodegenerative diseases","display_name":"Synthesis of ATP-competitive CK1\u03b4 inhibitors: exploring heteroaromatic systems as promising tools for neurodegenerative diseases","alternate_titles":[],"publication_year":2023,"publication_date":"2023-02-21","ids":{"openalex":"https://openalex.org/W7034209201"},"language":"en","primary_location":{"id":"pmh:oai:arts.units.it:11368/3041019","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11368/3041019","pdf_url":null,"source":{"id":"https://openalex.org/S4306400480","display_name":"ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142444530","host_organization_name":"University of Trieste","host_organization_lineage":["https://openalex.org/I142444530"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W7034209201"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090182086","display_name":"Ilenia Grieco","orcid":"https://orcid.org/0009-0008-6829-796X","observed_orcids":["https://orcid.org/0009-0008-6829-796X"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"GRIECO, ILENIA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5090182086"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.19820000231266022,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.07180000096559525,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/casein-kinase-1-delta","display_name":"CK1\u03b4","score":0.8169999718666077},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/benzothiazole-derivatives","display_name":"benzothiazole derivatives","score":0.8109999895095825},{"id":"https://openalex.org/keywords/riluzole","display_name":"riluzole","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hydrazine-derivatives","display_name":"hydrazine derivatives","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pyrazine-derivatives","display_name":"pyrazine derivatives","score":0.8889999985694885},{"id":"https://openalex.org/keywords/1-3-5-triazine-derivatives","display_name":"1,3,5-triazine derivatives","score":0.925000011920929},{"id":"https://openalex.org/keywords/molecular-hybridization","display_name":"molecular hybridization","score":0.6330000162124634},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7170000076293945},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.7689999938011169},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9399999976158142},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/molecular-simplification","display_name":"molecular simplification","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.7294999957084656},{"id":"https://openalex.org/C2779319286","wikidata":"https://www.wikidata.org/wiki/Q415744","display_name":"Riluzole","level":4,"score":0.6151000261306763},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5303000211715698},{"id":"https://openalex.org/C2775999725","wikidata":"https://www.wikidata.org/wiki/Q259997","display_name":"Hydroxylamine","level":2,"score":0.5133000016212463},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.46149998903274536},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4336000084877014},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.41350001096725464},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.40700000524520874},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3912999927997589},{"id":"https://openalex.org/C53345823","wikidata":"https://www.wikidata.org/wiki/Q5531554","display_name":"Gene isoform","level":3,"score":0.3783999979496002},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3779999911785126},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3668999969959259},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35920000076293945},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.3443000018596649},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3246999979019165},{"id":"https://openalex.org/C2778866207","wikidata":"https://www.wikidata.org/wiki/Q426278","display_name":"Quinazoline","level":2,"score":0.3215999901294708},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.30979999899864197},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.3095000088214874},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.30790001153945923},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.29649999737739563},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.28610000014305115},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.27959999442100525},{"id":"https://openalex.org/C2776597398","wikidata":"https://www.wikidata.org/wiki/Q5954496","display_name":"Hydrazine (antidepressant)","level":2,"score":0.2694999873638153}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:arts.units.it:11368/3041019","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11368/3041019","pdf_url":null,"source":{"id":"https://openalex.org/S4306400480","display_name":"ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142444530","host_organization_name":"University of Trieste","host_organization_lineage":["https://openalex.org/I142444530"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223403508","https://openalex.org/W3135282913","https://openalex.org/W7015067785","https://openalex.org/W4394579651","https://openalex.org/W4214831020","https://openalex.org/W3023847528","https://openalex.org/W2610781820","https://openalex.org/W7130915614","https://openalex.org/W7223111071"],"abstract_inverted_index":{"Casein":[0],"Kinase":[1,9],"1":[2],"isoform":[3],"\u03b4":[4],"(CK1\u03b4)":[5],"belongs":[6],"to":[7,83,117,174,188,205,215,260,363],"Protein":[8],"(PK)":[10],"superfamily":[11],"and":[12,20,31,61,116,133,160,171,184,200,246,265,269,320],"it":[13],"is":[14,39,96],"involved":[15],"in":[16,21,141,293,328],"several":[17,167,285],"cellular":[18],"processes":[19],"neurodegenerative":[22],"disorders":[23],"including":[24],"Alzheimer\u2019s":[25],"disease":[26,29],"(AD),":[27],"Parkinson\u2019s":[28],"(PD)":[30],"Amyotrophic":[32,77],"Lateral":[33,78],"Sclerosis":[34,79],"(ALS).":[35],"The":[36,65,99,225,332],"PhD":[37],"thesis":[38],"focused":[40],"on":[41,110,135],"the":[42,70,86,91,108,119,128,136,142,146,176,182,190,193,229,262,289,294,310,314,321,346,350,358,365,379],"development":[43,60],"of":[44,94,107,157,169,192,197,211,219,228,243,257,280,313,337,381,385],"ATP-competitive":[45,359],"CK1\u03b4":[46,111],"inhibitors":[47],"by":[48,308],"exploring":[49,221,284,373],"heteroaromatic":[50],"systems":[51],"applying":[52],"three":[53],"main":[54],"strategies:":[55],"metabolic-based":[56],"design,":[57],"new":[58,223],"scaffold":[59,68],"molecular":[62,274,304],"simplification":[63,275],"approach.":[64],"first":[66],"investigated":[67,233],"involves":[69],"benzo[d]thiazole":[71],"nucleus;":[72],"Riluzole,":[73],"approved":[74],"drug":[75],"for":[76],"(ALS),":[80],"has":[81,102],"proved":[82,187],"interact":[84],"with":[85,179,195,237],"glutamatergic":[87],"transmission":[88],"even":[89,287],"if":[90,288],"real":[92],"mechanism":[93],"action":[95],"still":[97],"unclear.":[98],"research":[100],"group":[101],"experimentally":[103],"demonstrated":[104],"an":[105,139,335],"activity":[106,140,256,336],"candidate":[109],"(IC50":[112,316,323],"=":[113,317,324],"16.1":[114],"\u03bcM)":[115,319,326],"corroborate":[118],"hypothesis,":[120],"since":[121],"Riluzole":[122],"underwent":[123],"a":[124,155,209,217,222,267,273,300,303,329,368],"strong":[125],"hepatic":[126],"metabolism,":[127],"N-hydroxylamine":[129],"derivative":[130,213,252,312],"was":[131,276,282,306,353,371],"developed":[132,165,283],"assayed":[134],"target":[137],"obtaining":[138,234],"same":[143],"range.":[144,297],"Moreover,":[145],"hydrazine":[147,161],"analogue":[148],"appears":[149],"as":[150,343,355,357,376,378],"another":[151,206],"appealing":[152],"precursor.":[153],"Therefore,":[154],"series":[156,194,218,279,315],"functionalized":[158],"hydroxylamine":[159],"derivatives":[162,186,349],"have":[163,231],"been":[164,232],"introducing":[166],"types":[168],"alkyl":[170],"arylalkyl":[172],"moieties":[173],"outline":[175],"SAR":[177,271],"profile":[178],"encouraging":[180],"results;":[181],"benzyl-":[183],"isopentyl-hydrazine":[185],"be":[189],"best":[191,311],"IC50s":[196,242],"1.62":[198],"\u03bcM":[199,339],"0.92":[201],"\u03bcM,":[202],"respectively.":[203],"Moving":[204],"heterocyclic":[207],"system,":[208],"screening":[210],"in-house":[212],"allowed":[214],"develop":[216],"pyrazines":[220],"scaffold.":[224],"four":[226],"positions":[227],"system":[230],"promising":[235,348],"results":[236],"two":[238],"lead":[239],"compounds":[240],"reporting":[241],"69":[244],"nM":[245],"200":[247],"nM.":[248],"Finally,":[249],"starting":[250],"from":[251],"5-(7-amino-5-(benzylamino)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-2-yl)benzen-1,3-diol":[253],"that":[254],"displayed":[255,334],"180":[258],"nM,":[259],"simplify":[261],"synthetic":[263],"approach":[264],"obtain":[266,299],"quicker":[268],"deepen":[270],"profile,":[272],"applied.":[277],"A":[278],"1,3,5-triazines":[281],"substituents":[286],"activities":[290],"registered":[291],"were":[292],"high":[295],"micromolar":[296],"To":[298],"hit":[301],"compound,":[302],"hybrid":[305,333],"achieved":[307,366],"combining":[309],"19.6":[318],"4-fluoro-1H-indazol-3-amine":[322],"24.9":[325],"discovered":[327],"fragment-based":[330],"work.":[331],"3.86":[338],"confirming":[340],"this":[341],"strategy":[342],"challenging.":[344],"For":[345],"most":[347],"CNS-prediction":[351],"permeability":[352],"estimated":[354],"well":[356,377],"behavior.":[360],"In":[361],"conclusion,":[362],"validate":[364],"results,":[367],"biological":[369],"characterization":[370],"conducted":[372],"neuroprotective":[374],"features":[375],"decrease":[380],"phosphorylated":[382],"TDP-43":[383],"(hallmark":[384],"ALS)":[386],"via":[387],"Western":[388],"Blot":[389],"analysis.":[390]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7034209201","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-10T00:00:00"}
